| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the 1Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
OBJECTIVE: To estimate a normal reference range for thyroid-stimulating hormone (TSH) at each point in gestation in singleton and twin pregnancies.
METHODS: All women enrolling for prenatal care from December 2000 through November 2001 underwent prospective TSH screening at their first visit. Separate nomograms were constructed for singleton and twin pregnancies using regression analysis. Values were converted to multiples of the median (MoM) for singleton pregnancies at each week of gestation.
RESULTS: Thyroid-stimulating hormone was evaluated in 13,599 singleton and 132 twin pregnancies. Thyroid-stimulating hormone decreased significantly during the first trimester, and the decrease was greater in twins (both P < .001). Had a nonpregnant reference (0.4–4.0 mU/L) been used rather than our nomogram, 28% of 342 singletons with TSH greater than 2 standard deviations above the mean would not have been identified. For singleton first-trimester pregnancies, the approximate upper limit of normal TSH was 4.0 MoM, and for twins, 3.5 MoM. Thereafter, the approximate upper limit was 2.5 MoM for singleton and twin pregnancies.
CONCLUSION: If thyroid testing is performed during pregnancy, nomograms that adjust for fetal number and gestational age may greatly improve disease detection. Values expressed as multiples of the median may facilitate comparisons across different laboratories and populations.
LEVEL OF EVIDENCE: II-2
This article has been cited by other articles:
|
|
 |
|
  J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF]
|
|
|
|
 |
|
 Subsection Reports J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47. [Full Text] [PDF]
|
|
|
|
|
|
M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Casey, J. S. Dashe, C. Y. Spong, D. D. McIntire, K. J. Leveno, and G. F. Cunningham Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy Obstet. Gynecol., May 1, 2007; 109(5): 1129 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Brent Diagnosing Thyroid Dysfunction in Pregnant Women: Is Case Finding Enough? J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 39 - 41. [Full Text] [PDF]
|
|
|
|
|
|
B. M. Casey and K. J. Leveno Thyroid disease in pregnancy. Obstet. Gynecol., November 1, 2006; 108(5): 1283 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Casey, J. S. Dashe, C. E. Wells, D. D. McIntire, K. J. Leveno, and F. G. Cunningham Subclinical Hyperthyroidism and Pregnancy Outcomes Obstet. Gynecol., February 1, 2006; 107(2): 337 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Dashe, B. M. Casey, E. C. Wells, D. D. McIntire, K. J. Leveno, and G. F. Cunningham Thyroid-Stimulating Hormone in Singleton and Twin Pregnancy: Importance of Gestational Age-Specific Reference Ranges Obstet. Gynecol., January 1, 2006; 107(1): 206 - 206. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Haddow, G. E. Palomaki, and M. R. McClain Thyroid-Stimulating Hormone in Singleton and Twin Pregnancy: Importance of Gestational Age-Specific Reference Ranges Obstet. Gynecol., January 1, 2006; 107(1): 205 - 206. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
